CYP1A2 and coffee intake and the modifying effect of sex, age, and smoking

The Rotterdam Study: 2012 objectives and design update

(2011) Albert Hofman et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Sequence variants at CYP1A1–CYP1A2 and AHR associate with coffee consumption

(2011) Patrick Sulem et al.   HUMAN MOLECULAR GENETICS

Genome-Wide Meta-Analysis Identifies Regions on 7p21 (AHR) and 15q24 (CYP1A2) As Determinants of Habitual Caffeine Consumption

(2011) Marilyn C. Cornelis et al.   PLoS Genetics

Caffeine and Blood Pressure Response: Sex, Age, and Hormonal Status

(2010) Noha H. Farag et al.   JOURNAL OF WOMENS HEALTH

Coffee consumption and CYP1A2 genotype in relation to bone mineral density of the proximal femur in elderly men and women: a cohort study

(2010) Helena Hallström et al.   Nutrition & Metabolism

CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension

(2009) Paolo Palatini et al.   JOURNAL OF HYPERTENSION

Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population

(2009) Arzu Gunes et al.   PHARMACOGENOMICS

In vitroInhibition of CYP1A2 by Model Inhibitors, Anti-Inflammatory Analgesics and Female Sex Steroids: Predictability ofin vivoInteractions

(2008) Marjo J. Karjalainen et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer

(2008) Shelley S. Tworoger et al.   CANCER

Coffee, tea, caffeine and risk of breast cancer: A 22-year follow-up

(2008) Davaasambuu Ganmaa et al.   INTERNATIONAL JOURNAL OF CANCER

Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms

(2008) Arzu Gunes et al.   PHARMACOGENOMICS